Novo Nordisk A/S (ADR)  

(Public, NYSE:NVO)   Watch this stock  
Find more results for NVO
+0.61 (1.11%)
Jul 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 55.21 - 55.64
52 week 46.17 - 60.34
Open 55.37
Vol / Avg. 638,844.00/1.36M
Mkt cap 111.72B
P/E 27.94
Div/yield 0.96/1.72
EPS 1.99
Shares 1.96B
Beta 0.83
Inst. own 10%

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 34.75% 32.30%
Operating margin 45.23% 45.81%
EBITD margin - 46.35%
Return on average assets 43.55% 41.29%
Return on average equity 90.02% 79.90%
Employees 41,571 -
CDP Score - 100 B


Novo Alle 1
+45-44-448888 (Phone)
+45-44-436633 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Novo Nordisk A/S is a healthcare company. The Company is engaged in discovery, development, manufacturing and marketing of pharmaceutical products. The Company's business segments include diabetes and obesity care, and biopharmaceuticals. The diabetes and obesity care segment covers insulins, glucagon-like peptide-1 (GLP-1), other protein-related products (such as glucagon, protein-related delivery systems and needles), oral anti-diabetic drugs and obesity. The biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. It offers a range of diabetes product, including new generation insulins and a portfolio of modern insulin. It provides Saxenda, which is a product to treat obesity and is available in Denmark, Italy and Canada. Its other products/compounds include Xultophy, Semaglutide (NN9535), Faster-acting insulin aspart (NN1218), N9-GP (NN7999), N8-GP (NN7088) and NN8640 Once-weekly human growth hormone.

Officers and directors

Goran A. Ando M.D. Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Lars Rebien Soerensen President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Jeppe Christiansen Vice Chairman of the Board
Age: 56
Bio & Compensation  - Reuters
Jesper Brandgaard Chief Financial Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Maziar Mike Doustdar Executive Vice President, International Operations
Age: 45
Bio & Compensation  - Reuters
Lars Fruergaard Joergensen Executive Vice President, Chief of Staff
Age: 49
Bio & Compensation  - Reuters
Mads Krogsgaard Thomsen Chief Science Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Jakob Riis Executive Vice President, China, Pacific & Marketing
Age: 50
Bio & Compensation  - Reuters
Jerzy Gruhn Executive Vice President, Europe
Age: 52
Bio & Compensation  - Reuters
Jesper Hoeiland Executive Vice President, US
Age: 55
Bio & Compensation  - Reuters